Sonoma Biotherapeutics has announced positive interim results from its ongoing phase 1 Regulate-RA trial evaluating ...
Faster scans and same-day results improve patient experience across community sites United Lincolnshire Teaching Hospitals NHS Trust has upgraded its three Community Diagnostics Centres (CDCs) in ...
Domain Therapeutics has announced the first patients have been dosed in its phase 1/2 DOMISOL clinical trial of DT-7012, a ...
Qureight’s Vascul8 model has been validated in a peer-reviewed study marking a significant advance in the treatment of ...
Evotec SE has announced a $25m milestone payment from Bristol Myers Squibb, recognising scientific progress made within their ...
Incyte has announced promising new data from its phase 3b TRuE-AD4 trial of Opzelura (ruxolitinib cream) in adults with moderate atopic dermatitis (AD), revealing significant improvements in clinical ...
Astellas Pharma has unveiled encouraging preliminary findings from its ongoing phase 4 OPTION-VMS observational study, ...
Straightforward accreditation standards: Teams will save time and effort by creating workflows around accreditation standards ...
CHMP backs once-weekly subcutaneous option for systemic lupus erythematosus AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback